Author:
Schiff Michael,Takeuchi Tsutomu,Fleischmann Roy,Gaich Carol L.,DeLozier Amy M.,Schlichting Douglas,Kuo Wen-Ling,Won Ji-Eon,Carmack Tara,Rooney Terence,Durez Patrick,Shaikh Saeed,Hidalgo Rodolfo Pardo,van Vollenhoven Ronald,Zerbini Cristiano A. F.
Funder
Eli Lilly and Company and Incyte Corporation
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Fleischmann R, Schiff M, van der Heijde D, Ramos-Remus C, Spindler A, Stanislav M, Zerbini CAF, Gurbuz S, Dickson C, de Bono S, et al. Baricitinib, methotrexate, or combination in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment. Arthritis Rheumatol. 2017;69:506–17. doi:
10.1002/art.39953
.
2. Bruce B, Fries JF. The Health Assessment Questionnaire (HAQ). Clin Exp Rheumatol. 2005;23:S14–8.
3. Ramey D, Fries J, Singh G. The Health Assessment Questionnaire 1995 — status and review. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia: Lippincott-Raven; 1996. p. 227–37.
4. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum. 1993;36:729–40.
5. Kirwan JR, Newman S, Tugwell PS, Wells GA, Hewlett S, Idzera L, et al. Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9. J Rheumatol. 2009;36:2071–6.
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献